The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic and predictive value of baseline derived neutrophil-to-lymphocyte ratio (dNLR) in RAS wild-type (WT) metastatic colorectal cancer (mCRC) receiving 5-fluorouracil and folinic acid (FU/FA) with or without panitumumab (Pmab) maintenance: A post-hoc analysis of the PANAMA/AIO KRK 0212) trial.
 
Tobias Schaetzl
No Relationships to Disclose
 
Dominik Modest
Honoraria - 21up; Abbvie; Amgen; AstraZeneca; Bicara Therapeutics; Bristol-Myers Squibb; Cor2Ed; GlaxoSmithKline; IKF Klinische Krebsforschung; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Lilly; Merck; Merck Serono; Onkowissen; Pierre Fabre; Regeneron; Rottapharm Biotech; Seagen; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Abbvie; AIO gGmbH; Amgen; Cor2Ed; GlaxoSmithKline; IKF Klinische Krebsforschung; Incyte; Jazz Pharmaceuticals; Lilly; Merck Serono; Onkowissen; Onkowissen; Pierre Fabre; Regeneron; SERVIER; Takeda
Research Funding - Amgen (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER
 
Sebastian Stintzing
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb GmbH; Daiichi Sankyo Europe GmbH; Merck KGaA; MSD; Nordic Bioscience; Pfizer; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; CV6 Therapeutics; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Isofol Medical; Merck KGaA; MSD; Nordic Bioscience; Pierre Fabre; Roche; Seagen; SERVIER; TERUMO
Research Funding - Amgen (Inst); Merck Serono (Inst); MSD (Inst); Pierre Fabre (Inst); Roche Molecular Diagnostics (Inst)
Patents, Royalties, Other Intellectual Property - Servier (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Lilly; Merck KGaA; Pierre Fabre; Roche; Sanofi; Sirtex Medical; Takeda
 
Lothar Müller
No Relationships to Disclose
 
Ullrich Graeven
Stock and Other Ownership Interests - Bayer Germany; Biontech
Honoraria - Amgen; AstraZeneca; Celltrion; Ipsen; Takeda
Consulting or Advisory Role - Amgen
Research Funding - AstraZeneca (Inst); Epizyme (Inst); Mirati Therapeutics (Inst)
 
Ludwig Fischer Von Weikersthal
No Relationships to Disclose
 
Stefan Kasper
Employment - University Hospital Essen (I)
Honoraria - Amgen; Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Lilly; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi/Aventis; SERVIER; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Incyte; Janssen-Cilag; Lilly; Merck Serono; MSD Oncology; Novartis; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Roche/Genentech; SERVIER
Travel, Accommodations, Expenses - Amgen; BeiGene; BMS; Lilly; Merck Serono; Pierre Fabre; Roche; Sanofi
Other Relationship - Amgen; Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Sanofi
 
Eray Goekkurt
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Bristol-Myers Squibb; MSD; Pfizer
 
Anke Reinacher-Schick
Honoraria - Amgen; Pierre Fabre; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; MCI Deutschland; Roche; Roche
Research Funding - Acurs Biosciences Europa (Inst); AIO-Studien (Inst); BioNTech (Inst); Charité - Universitätsmedizin Berlin (Inst); Genentech (Inst); Georg-August-Universität Göttingen (UMG) (Inst); Johannes Gutenberg-Universität Mainz (Inst); Merck (Inst); Rafael Pharmaceuticals (Inst); Resilience Care (Inst); Roche (Inst); Universitätsklinikum Ulm (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MCI Deutschland; Roche; Roche
 
Karel Caca
No Relationships to Disclose
 
Annabel Alig
Honoraria - Amgen; BMS GmbH & Co. KG; Merck KGaA; MSD; Pfizer; Pierre Fabre; Roche; SERVIER
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Merck KGaA; MSD; Nordic Group; Pfizer; Pierre Fabre; Roche; SERVIER
 
Annika Kurreck
Honoraria - Amgen; SERVIER; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; Medac; SERVIER
 
Beeke Hoppe
No Relationships to Disclose
 
Johanna Meyer-Knees
No Relationships to Disclose
 
Tonio Lang
No Relationships to Disclose
 
David Horst
No Relationships to Disclose
 
Armin Jarosch
No Relationships to Disclose
 
Volker Heinemann
Stock and Other Ownership Interests - BioNTech SE
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck; MSD; Novartis; Oncosil; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; SERVIER; Sirtex Medical
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; GlaxoSmithKline; IOMX; Isofol Medical; Janssen; Merck; MSD; Natera; Nordic Bioscience; Oncosil; Pierre Fabre; Roche; Servier/Pfizer; SYSMEX; Takeda
Research Funding - Amgen (Inst); Merck (Inst); Roche (Inst); Servier (Inst)
Expert Testimony - Oncosil; Servier
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Merck; MSD; Nordic Bioscience
 
Tanja Trarbach
No Relationships to Disclose
 
Arndt Stahler
Honoraria - Amgen; Daiichi Sankyo Europe GmbH; Lilly; Merck KGaA; MSD; Takeda
Consulting or Advisory Role - SERVIER; Takeda
Research Funding - Merck KGaA (Inst); Treos Bio (Inst)
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo Europe GmbH; Lilly; Merck KGaA; Pfizer; Roche; SERVIER